Rivaroksaban kompanii «Bayer» znachitel'no (na 24%) snizhaet risk insul'ta, serdechno-sosudistoy smerti i infarkta miokarda u patsientov s khronicheskoy ishemicheskoy bolezn'yu serdtsa ili zabolevaniem perifericheskikh arteriy
- Authors: - -
- Issue: Vol 19, No 10 (2017)
- Pages: 146-147
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/94960
- ID: 94960
Cite item
